Anti-Interleukin-6 Receptor Antibody Therapy-Induced Retinopathy in a Patient with Rheumatoid Arthritis
Figure 3
Serum concentrations of IL-6 and IL-8 before and after tocilizumab administration. Marked increases in the serum levels of IL-6 are observed 1 and 4 months after tocilizumab administration that did not affect the serum levels of IL-8.
